To evaluate the feasibility of using autofl uorescence bronchoscopy after sputum examination for early detection of large airway lung cancer and factors associated with the presence of cancerous and prec ancerous lesions among smokers with silicosis.
were respectively 63 ± 10 years and 51 ± 30 pack-years. Intraepithelial lung cancers and pre-neoplastic lesions (squamous metaplasia or above) were detected in respectively 2 (4.2%) and 14 (29.2%) subjects. The proportions of current smokers (75.0% vs. 40.6%, P = 0.03) and asbestos exposure (37.5% vs. 9.4%, P = 0.04) were signifi cantly higher in subjects with the above lesions compared with those without. C O N C L U S I O N S : Sputum examination followed by autofl uorescence bronchoscopy may be a useful way of identifying cancerous/pre-cancerous lesions among silicotic smokers. Current smoking and asbestos exposure were associated with these lesions. K E Y W O R D S : lung cancer; silicosis; autofl uorescence bronchoscopy; early detection LUNG CANCER is the leading cause of cancerr elated deaths, with a dismal 5-year survival of less than 15%. 1 The prognosis of lung cancer patients is closely related to tumour size and stage of disease. 2 More than 90% of patients with early central airway cancer survived at 5 years with either surgical or bronchoscopic treatment. 3, 4 Smokers with silicosis are at increased risk of developing lung cancer. 5 However, the background radiological abnormalities of silicosis make radiological detection of lung cancer diffi cult. 6 Sputum cytology examination is sensitive in detecting central airway lung cancers. 7 It has been shown that the presence of moderate atypia or worse in sputum may predict squamous cell carcinoma in individuals at high risk for lung cancer. 8 Autofl uorescence bronchoscopy, which utilises the spectral difference in fl uorescence and absorption
S U M M A R Y
prop erties between normal and abnormal bronchial epithelium, is several times more sensitive in detecting pre-neoplastic lesions and intraepithelial lung cancers than conventional white-light bronchoscopy (WLB). 9, 10 While some studies have shown that sputum cytology examination followed by autofl uorescence bronchoscopy is a practical way of identifying early central lung cancers among smokers, 11 others have failed to prove its superiority in detecting precancerous lesions over WLB. 12 The discrepancy may be due to the population screened. To date, no studies have been performed on the role of this early detection tool in detecting pre-cancerous and early cancerous lesions among patients with silicosis in whom radiological screening is not appropriate. 6 The use of autofl uorescence bronchoscopy may also help to delineate factors associated with the presence of these subtle endobronchial lesions.
The purpose of the present study was to evaluate the feasibility of using autofl uorescence bronchoscopy AIL and YH contributed equally to the writing of this article.
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MATERIALS AND METHODS

Study subjects
From June 2006 to March 2009, all patients followed up at the designated Pneumoconiosis Clinic of Hong Kong were invited to join the study if they fulfi lled the following inclusion criteria: 1) age ⩾40 years; 2) smok ing history of ⩾20 pack-years; and 3) confi rmed diagnosis of silicosis. The diagnosis of silicosis was based on signifi cant occupational exposure to silica-containing dust and radiographic changes consistent with silicosis, with or without histological proof. 13 A 'confi rmed' case of silicosis was determined by the Pneumoconiosis Medical Board, an offi cial committee for pneumoconiosis compensation assessment in Hong Kong.
Demographic and clinical characteristics, occupational exposure, smoking history, profusion score of pneumoconiotic nodules and the size of progressive massive fi brosis (PMF) were documented. 14 An exsmoker was defi ned as a smoker who had quit for ⩾1 year; all other smokers were regarded as current.
Sputum examination
From June 2006 to August 2008, subjects were asked to provide early morning sputum for 3 consecutive days. All fresh specimens were examined by trained cytotechnologists under the supervision of a pathologist (SYL) in the Cytology Laboratory of the Department of Health. The results were reported as unsatisfactory, normal, atypia, suspicious for cancer and cancer. 15 From September 2008 to March 2009, sputum samples were collected through sputum induction using Lung Flute (Medical Acoustics, Buffalo, NY, USA), which is particularly useful for patients unable to produce sputum spontaneously. 16 In addition to the cytology examination, all sputum samples were sent for cytometry examination using an automated high-resolution image cytometer (LungSign™, Perceptronix Medical Inc Laboratories, Vancouver, BC, Canada). Both lung cancer likelihoodrelated LungSign score and DNA ploidy index were reported. 17 Subjects with a cytology report of sputum atypia or above or a sputum cytometry report of indeterminate or increased likelihood of malignancy or abnormal DNA index were invited to undergo bronchoscopy and spirometry at the Queen Mary Hospital, the main teaching hospital of the University of Hong Kong.
Bronchoscopy
Bronchoscopic examination was performed under local anaesthesia in the endoscopy suite by a bronchoscopist (BL) who was experienced in performing autofl uorescence bronchoscopy. Conventional WLB was performed fi rst, followed by autofl uorescence bronchoscopy (SAFE-1000 System of Autofl uorescence Endoscopy, Pentax, Asahi Optical, Tokyo, Japan, or Autofl uorescence Imaging, Olympus, Tokyo, Japan). Both systems have been demonstrated to have a sensitivity of >90% in the detection of precancerous lesions and carcinoma in situ (CIS) by previous clinical studies. 18 All abnormal sites detected by WLB, autofl uorescence bronchoscopy or both were videotaped, recorded and biopsied. The location of each biopsy in the bronchial tree was precisely recorded using the international bronchial location classifi cation. 19 All biopsy specimens were examined by qualifi ed pathologists and classifi ed according to the World Health Organization classifi cation into normal; hyperplasia; metaplasia; mild, moderate, or severe grade dysplasia; CIS; and invasive carcinoma. 20 
Spirometry
Standard spirometry was performed before bronchoscopy by qualifi ed technicians using Vmax (Viasys SensorMedics, Yorba Linda, CA, USA). Forced expiratory volume in one second (FEV 1 ) and forced vital capacity (FVC) were measured and expressed as a percentage of the predicted value based on a prediction equation for the Chinese population. 21 Airfl ow limitation was defi ned as a ratio of FEV 1 to FVC of <70%. 22 
Management
Patients with invasive lung cancer were managed according to the current standard of care. 18 Subjects with intraepithelial lung cancer (severe dysplasia and CIS) were treated with endobronchial cryotherapy (ERBE Elektromedizin GmbH, Tübingen, Germany) and reassessed periodically with WLB and autofl uorescence bronchoscopy at 3, 6, 12 and 24 months. Subjects with pre-neoplastic lesions (squamous metaplasia and dysplasia) were followed up with WLB and autofl uorescence bronchoscopy every 6 months until the lesions regressed. All abnormal sites detected and sites that had received treatment were biopsied at re-assessment. We gave general physician's advice for smoking cessation to all participants in the study.
Outcome
The outcome of this cohort, including the number of patients with lung cancer and the stage distribution, was determined from patient records reviewed in July 2009.
Ethical considerations
Ethical approval was obtained from the institutional review board of both the Department of Health and the University of Hong Kong. Informed consent was obtained from each subject.
Statistical analysis
Subjects were divided into two groups for analyses: Group 1 included patients with endobronchial biopsy revealing squamous metaplasia or above, and Group 2 those without endobronchial lesion or biopsy showing hyperplasia or below. Continuous data were expressed as mean ± standard deviation (SD) and categorical data were presented as percentage. The Fisher's exact test and the two independent sample t-tests were used to compare dichotomous and continuous data between the two groups. P < 0.05 was considered statistically signifi cant. SPSS 15.0 for Windows (Statistical Package for Social Sciences, Chicago, IL, USA) was used for all statistical analyses.
RESULTS
Demographic characteristics
From June 2006 to March 2009, we screened 720 subjects with silicosis. A fi nal total of 48 eligible Chinese male subjects with sputum abnormalities were recruited into the study. The mean age of this cohort was 63 ± 10 years (range 48-82), with an accumulated smoking history of 51 ± 30 pack-years. The demographic data, occupational exposure, spirometric results and type of sputum abnormality are shown in Table 1 .
Sputum abnormality, bronchoscopy and lung cancer
Among the 48 subjects with sputum abnormality, 37 (77.1%) had sputum atypia and 11 (22.9%) had abnormal cytometry (Table 1) .
Endobronchial lesions were detected in 30 (62.5%) subjects and a total of 69 biopsies were performed: 12 (17.4%) were in the right upper lobe, 8 (11.6%) in the right middle lobe, 18 (26.1%) in the right lower lobe, 21 (30.4%) in the left upper lobe, 8 (11.6%) in the left lower lobe, 1 (1.4%) in the left main bronchus, and 1 (1.4%) in the carina. Among the 69 biopsies performed, 17 (24.6%) were found to be squamous metaplasia or above.
Of the 48 subjects recruited, 2 (4.2%) were found to have intraepithelial neoplasm (CIS or severe dysplasia), 4 (8.4%) had mild to moderate dysplasia, 10 (20.8%) had squamous metaplasia and 14 (29.2%) showed either infl ammation or normal epithelium.
There were no signifi cant differences in the proportions of subjects harbouring squamous metaplasia or worse between subjects with abnormal sputum cytology and those with cytometry abnormality (32.4% vs. 36.4%, P = 0.81) and between subjects providing early morning sputum and those providing induced sputum (34.3% vs. 30.8%, P = 0.82).
Compared to subjects with normal bronchoscopic fi ndings or biopsy showing hyperplasia or below, the proportion of current smokers (75.0% vs. 40.6%, P = 0.03) and exposure to asbestos (37.5% vs. 9.4%, P = 0.04) were signifi cantly higher in those harbouring epithelial metaplasia or above. There was no statistically signifi cant difference in chest symptoms, comorbidities, spirometric results, profusion score and PMF size between the two groups ( Table 2) .
Outcome
With a median follow-up of 23.8 months, no other lung cancer cases were diagnosed in this cohort other than the two detected by screening. For the two with 
DISCUSSION
It is generally accepted that squamous cell carcinoma develops in a gradual and stepwise fashion from normal epithelium, to hyperplasia, squamous metaplasia, dysplasia, and towards CIS and invasive carcinoma. 20 If the pre-cancerous and pre-invasive lesions can be detected and treated, the development of lung cancer may be arrested. By using a combination of sputum cytology/ c ytometry and autofl uorescence bronchoscopy as a screening tool, we found that 4.2% of the silicotic patients with sputum abnormality had intraepithelial (Stage 0) lung cancer. Previous research has shown that the progression rates from severe dysplasia to CIS/invasive cancer and from CIS to invasive cancer were respectively 32% and 21% over 4 to 17 months. 23 If no intervention was performed, respectively a third and more than half of the patients harbouring these lesions would develop invasive lung cancer at 1 and 2 years. 24 In our two subjects with intraepithelial neoplasm who received endobronchial cryotherapy, no tumour progression was observed during the follow-up period. For those subjects without intraepithelial neoplasm, no malignancy was detected with a median follow-up of nearly 2 years.
In our cohort, squamous metaplasia and mild to moderate dysplasia were detected in 29.2% of the subjects. Although squamous metaplasia is sometimes regarded as a benign and reversible process, up to 9% of patients progress to intraepithelial lung cancer with a median follow-up of 21 months. 23 The progression rate is similar to that of mild to moderate dysplasia. 25 Subjects harbouring these lesions should also therefore be followed up regularly.
Pre-cancerous or cancerous lesions were identifi ed in a third of our patients. Current smoking and a history of asbestos exposure were associated with an increased risk of such lesions. Our fi ndings suggest that autofl uorescence bronchoscopy is essential for silicotic patients presenting with sputum abnormalities, particularly in the case of current smokers or those with a history of exposure to asbestos.
In our cohort, the positive yields of autofl uorescence bronchoscopy were similar in patients undergoing sputum cytology and those with cytometry as the initial test. Given its low cost and wide availability, conventional sputum cytology remained a good choice for initial lung cancer screening among smokers with silicosis. Previous studies have demonstrated that automated sputum DNA cytometry had comparable effi cacy in detecting central airway lung cancer to that of conventional sputum cytology. 17, 26 Our study fi ndings further confi rm that sputum DNA abnormality detected by automated cytometry should be investigated in the same way as sputum atypia, and that bronchoscopic examination with AFB, if available, is a good option.
Our study had several limitations. First, peripherally located lung cancers, especially adenocarcinoma, may have been missed in our cohort as computed tomography (CT) of the thorax was not used. However, our target population consisted of silicotic males with a smoking history in whom the relative risk for squamous cell carcinoma was much higher than that of adenocarcinoma. It is therefore reasonable to assume that few peripheral lung cancers, which were not our screening target, would be missed. In addition, CT thorax might be inappropriate for lung cancer detection in silicotic patients due to the background radiological abnormalities. 6 Second, we have no follow-up data for those who were screened but who could not be recruited into the study due to limited resources. Third, this pilot study involved only a small number of subjects, and the conclusions of the study need to be verifi ed in a larger cohort. 
R É S U M É R E S U M E N M A R C O D E R E F E R E N C I A S :
Los fumadores que padecen silicosis presentan un riesgo aumentado de cáncer de pulmón. O B J E T I V O : Evaluar la factibilidad de practicar la broncoscopia fl uorescente después del examen del esputo, con el fi n de detectar en forma temprana la presencia de lesiones cancerosas y precancerosas en los fumadores que sufren de silicosis.
M É T O D O S :
Se incluyeron en el estudio pacientes de la consulta de neumoconiosis cuando cumplían con los siguientes criterios: 1) tener ⩾40 años de edad; 2) presentar antecedentes de tabaquismo ⩾20 paquetes-año; y 3) tener un diagnóstico confi rmado de silicosis. Se recogerían muestras de esputo para examen citológico y en los pacientes con resultados anormales en la muestra de esputo citométrico y se practicaría la broncoscopia fl uorescente.
R E S U LTA D O S :
Se incluyeron 48 pacientes durante el período del estudio. La media de la edad fue 63 ± 10 años y del tabaquismo 51 ± 30 paquetes-año. Se detectaron lesiones de cáncer intraepitelial del pulmón en dos personas (4,2%) y lesiones precancerosas (metaplasia escamosa o más avanzadas) en 14 (29,2%). La proporción de fumadores actuales (75,0% contra 40,6%; P = 0,03) y de exposición al amianto (37,5% contra 9,4%; P = 0,04) fue signifi cativamente mayor en las personas que albergaban las lesiones precancerosas, en comparación con las personas que no las presentaban. C O N C L U S I Ó N : El examen del esputo seguido de broncoscopia fl uorescente podría ser una estrategia efi caz de detección de las lesiones cancerosas y precancerosas en los fumadores silicóticos. El tabaquismo actual y la exposición al amianto se asociaron con la presencia de estos tipos de lesiones.
